Skip to main content

UPDATE 4-Novartis CEO feels heat on U.S. generics, Cosentyx drop

* Cosentyx sales drop since Q4 worries analysts (Adds comments from CEO, updates shares)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.